X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (310) 310
oncology (205) 205
17p deletion (168) 168
female (165) 165
index medicus (155) 155
male (151) 151
hematology (127) 127
middle aged (111) 111
aged (99) 99
prognosis (99) 99
adult (97) 97
17p (76) 76
chronic lymphocytic leukemia (73) 73
mutation (72) 72
chromosome deletion (71) 71
chromosomes, human, pair 17 (71) 71
cancer (69) 69
genetics & heredity (65) 65
leukemia, lymphocytic, chronic, b-cell - genetics (64) 64
chromosomes, human, pair 17 - genetics (63) 63
child (61) 61
aged, 80 and over (60) 60
cll (60) 60
in situ hybridization, fluorescence (59) 59
chromosome aberrations (51) 51
survival (50) 50
p53 (49) 49
open-label (45) 45
leukemia (43) 43
tumor suppressor protein p53 - genetics (43) 43
deletion (42) 42
gene deletion (41) 41
adolescent (40) 40
mutations (40) 40
child, preschool (39) 39
cytogenetics (38) 38
fludarabine (37) 37
genes, p53 (36) 36
genetic aspects (36) 36
ibrutinib (36) 36
leukemia, lymphocytic, chronic, b-cell - drug therapy (36) 36
primitive neuroectodermal tumors (35) 35
medulloblastoma - genetics (34) 34
comparative genomic hybridization (33) 33
karyotyping (33) 33
medulloblastoma (33) 33
rituximab (33) 33
stem-cell transplantation (33) 33
tp53 (32) 32
loss of heterozygosity (31) 31
abnormalities (30) 30
expression (30) 30
central-nervous-system (29) 29
therapy (29) 29
disease progression (28) 28
pathology (28) 28
chromosome mapping (27) 27
molecular sequence data (27) 27
research (27) 27
base sequence (26) 26
cell biology (26) 26
chronic lymphocytic-leukemia (26) 26
leukemia, lymphocytic, chronic, b-cell - pathology (26) 26
phenotype (26) 26
polymerase chain reaction (26) 26
treatment outcome (26) 26
antineoplastic agents - therapeutic use (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
heterozygosity (25) 25
leukemia, lymphocytic, chronic, b-cell - therapy (25) 25
biochemistry & molecular biology (24) 24
chemotherapy (24) 24
chromosome 17p (24) 24
hemic and lymphatic diseases (24) 24
initial therapy (24) 24
leukemia, lymphocytic, chronic, b-cell - mortality (24) 24
medicine & public health (24) 24
survival analysis (24) 24
clinical neurology (23) 23
gene (23) 23
tumor proteins (23) 23
venetoclax (23) 23
analysis (22) 22
apoptosis (22) 22
care and treatment (22) 22
cerebellar neoplasms - genetics (22) 22
genomic aberrations (22) 22
risk factors (22) 22
survival rate (22) 22
tp53 mutation (22) 22
acute myeloid-leukemia (21) 21
cd38 expression (21) 21
health aspects (21) 21
hematology, oncology and palliative medicine (21) 21
in-situ hybridization (21) 21
infant (21) 21
tumor-suppressor gene (21) 21
cyclophosphamide (20) 20
development and progression (20) 20
disease-free survival (20) 20
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (403) 403
French (5) 5
Polish (5) 5
Hungarian (2) 2
Czech (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 08/2018, Volume 182, Issue 4, pp. 504 - 512
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 14, pp. 1647 - 1655
Journal Article
BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 08/2018, Volume 182, Issue 4, pp. 504 - 512
Patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) with deletion 17p [del(17p)] have poor outcomes with chemoimmunotherapy.... 
GENOMIC COMPLEXITY | CLL | TP53 MUTATION | 17p deletion | OPEN-LABEL | CLONAL EVOLUTION | PHASE-2 | SINGLE-ARM | ibrutinib | chronic lymphocytic leukaemia | THERAPY | RITUXIMAB | LEUKEMIA | HEMATOLOGY | BTK inhibitor
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 04/2012, Volume 157, Issue 1, pp. 67 - 74
Journal Article
Cytogenetic and Genome Research, ISSN 1424-8581, 08/2017, Volume 152, Issue 1, pp. 29 - 32
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 11/2018, Volume 18, Issue 11, pp. e493 - e499
We analyzed 44 patients with newly diagnosed systemic light-chain amyloidosis (AL) and del 17p, a rare finding in AL. Predictors of overall and... 
Plasma cells | AL amyloidosis | Prognosis | Deletion 17p | FISH cytogenetics | MULTIPLE-MYELOMA | SURVIVAL | TRANSLOCATION T(11/14) | BORTEZOMIB | STAGING SYSTEM | IMPACT | ONCOLOGY | CLINICAL-TRIALS | HEMATOLOGY
Journal Article
Journal Article